Jess Fiedorowicz is Head and Chief of the Department of Mental Health at the Ottawa Hospital and a Professor and Senior Research Chair in Adult Psychiatry in the Department of Psychiatry at the University of Ottawa. He is a scientist in the Clinical Epidemiology and Neurosciences Programs of the Ottawa Hospital Research Institute and a member of the uOttawa Brain & Mind Research Institute. Outside of his roles in Ottawa, he also serves as Editor-in-Chief of the Journal of Psychosomatic Research and as a member of the U.S. Food and Drug Association Psychopharmacologic Drugs Advisory Committee.
He graduated summa cum laude from Marquette University and with Honors in Research from the Medical College of Wisconsin. He completed a medicine (transitional year) internship at St. Luke’s Hospital in Milwaukee, Wisconsin followed by a psychiatry residency at the Johns Hopkins Hospital, where he additionally served as a chief resident. He completed a fellowship in the Clinical Neurobiology of the Major Psychoses at the University of Iowa and concurrently completed an M.S. in Clinical Investigation. He later obtained a Ph.D. in Translational Biomedicine and then a graduate certificate in biostatistics from the University of Iowa. His content expertise centers around morbidity and mortality (especially cardiovascular disease and suicide) in bipolar disorder and methods expertise relates to quantitative methods in epidemiology. He values taking an interdisciplinary, team science approach to his work. Clinically, he is board certified in psychiatry by the American Board of Psychiatry and Neurology and in obesity medicine by the American Board of Obesity Medicine.
Content Expertise: Morbidity and mortality in bipolar disorder with a focus on the two main causes of excess death: suicide and vascular disease
Methods Expertise: Quantitative methods in epidemiology
Fiedorowicz JG#*, Persons JE*, Assari S, Ostacher MJ, Goes FS, Nurnberger JI, Coryell WH. Moderators of the association between depressive, manic, and mixed mood symptoms and suicidal ideation and behavior: An analysis of the National Network of Depression Centers Mood Outcomes Program, Journal of Affective Disorders, 2021; 281: 623-630. * Authors Contributed Equally
*Goldstein BI, Baune BT, Bond D,J Chen P-H, Eyler L, Fagiolini A, Gomes F, Hajek T, Hatch J, McElroy SL, McIntyre RS, Prieto M, Sylvia LG, Tsai S-Y, Kcomt A, *Fiedorowicz JG. Call to action regarding the vascular-bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders, Bipolar Disorders, 2020; 22(5): 440-460. * Authors Contributed Equally
Fiedorowicz JG#, Persons J, Assari S, Ostacher M, Wang P, Zandi P, Thase M, Frye M, Coryell W. Depressive symptoms carry and increased risk for suicidal ideation and behavior in bipolar disorder without any additional contribution of mixed symptoms. Journal of Affective Disorders, 2019; 246: 775-782.
Persons J, Coryell W, Solomon DA, Keller MB, Endicott J, Fiedorowicz JG. Mixed state and suicide: Is the effect of mixed state on suicidal behavior more than the sum of its parts? Bipolar Disorders, 2018; 20(1): 35-41.
Fiedorowicz JG#, Endicott J, Leon AC, Solomon DA, Coryell W. Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder, American Journal of Psychiatry 2011; 168(1): 40-48.
Fiedorowicz JG#, Solomon DA, Leon AC, Endicott J, Li C, Rice JP, and Coryell WH. Manic/hypomanic symptom burden predicts cardiovascular mortality with bipolar disorder in the Collaborative Depression Study, Psychosomatic Medicine 2009, 71(6): 598-606.
